Charles River Laboratories and Medical Research

Selected news for the company - Charles River Laboratories, and the healthcare topic - Medical Research. We have 1,595 shared news items for this connection to-date.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/12/2022 Charles River Laboratories International, Inc. (NYSE:CRL) Expected to Post Quarterly Sales of $891.50 Million Wall Street brokerages expect Charles River Laboratories International, Inc. (NYSE:CRL) to report $891.50 million in sales for the current quarter, according to Zacks . Five analysts have issued estimates for Charles River Laboratories International‚Aos ... last released its earnings results on Tuesday, November 2nd. The medical research company reported $2.70 earnings per share for the quarter, beating the Zacks‚Ao consensus estimate of $2.58 by $0.12. The firm had revenue ...
1/5/2022 Charles River Laboratories International, Inc. (NYSE:CRL) Stock Position Cut by Congress Asset Management Co. MA - Transcript Daily Congress Asset Management Co. MA reduced its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 4.8% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 447,277 shares of the medical research company‚Aos stock after selling 22,741 shares during the quarter. Charles River Laboratories International makes up about 1.4% of Congress Asset ...
12/29/2021 Dupont Capital Management Corp Has $2.54 Million Position in Charles River Laboratories International, Inc. (NYSE:CRL) - WKRB News Dupont Capital Management Corp lowered its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 34.4% in the third quarter, according to its most recent disclosure with the SEC. The fund owned 6,147 shares of the medical research company‚Aos stock after selling 3,219 shares during the period. Dupont Capital Management Corp‚Aos holdings in Charles River Laboratories International were worth $2,537,000 as of its most recent ...
12/6/2021 Hotaling Investment Management LLC Has $380,000 Holdings in Charles River Laboratories International, Inc. (NYSE:CRL) Hotaling Investment Management LLC increased its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 5.7% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 920 shares of the medical research company‚Aos stock after purchasing an additional 50 shares during the period. Hotaling Investment Management LLC‚Aos holdings in Charles River Laboratories ...
12/5/2021 $891.50 Million in Sales Expected for Charles River Laboratories International, Inc. (NYSE:CRL) This Quarter Analysts predict that Charles River Laboratories International, Inc. (NYSE:CRL) will report sales of $891.50 million for the current fiscal quarter, Zacks reports. Five analysts have made estimates for Charles River Laboratories International‚Aos earnings ... last released its earnings results on Tuesday, November 2nd. The medical research company reported $2.70 earnings per share (EPS) for the quarter, beating the Thomson Reuters‚Ao consensus estimate of $2.58 by $0.12. Charles River ...
10/19/2021 Natixis Acquires Shares of 5,980 Charles River Laboratories International, Inc. (NYSE:CRL) - Transcript Daily Natixis bought a new stake in Charles River Laboratories International, Inc. (NYSE:CRL) in the 2nd quarter, according to its most recent filing with the SEC. The fund bought 5,980 shares of the medical research company‚Aos stock, valued at approximately $2,212,000.Several other institutional investors and hedge funds have also recently bought and sold shares of CRL. Vanguard Group Inc. lifted its stake in shares of Charles River Laboratories ...
10/16/2021 Public Sector Pension Investment Board Buys New Position in Charles River Laboratories International, Inc. (NYSE:CRL) The Markets Daily Public Sector Pension Investment Board purchased a new stake in Charles River Laboratories International, Inc. (NYSE:CRL) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 7,880 shares of the medical research company‚Aos stock, valued at approximately $2,915,000. A number of other institutional investors and hedge funds have also bought and sold shares of CRL. Viking Global Investors ...
9/30/2021 Globeflex Capital L P Sells 198 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - The Cerbat Gem Globeflex Capital L P lowered its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 2.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 6,583 shares of the medical research company‚Aos stock after selling 198 shares during the quarter. Globeflex Capital L P‚Aos holdings in Charles River Laboratories International were worth $2,435,000 as ...
9/27/2021 Xponance Inc. Has $2.78 Million Holdings in Charles River Laboratories International, Inc. (NYSE:CRL) - American Banking News American Banking News Xponance Inc. cut its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 22.8% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,527 shares of the medical research company‚Aos stock after selling 2,229 shares during the period. Xponance Inc.‚Aos holdings in Charles River Laboratories International were worth $2,784,000 as of its ...
9/27/2021 Xponance Inc. Has $2.78 Million Holdings in Charles River Laboratories International, Inc. (NYSE:CRL) - Ticker Report Ticker Report Xponance Inc. cut its position in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 22.8% in the second its most recent 13F and Exchange Commission (SEC). The institutional investor owned 7,527 shares of the medical research company‚Aos stock after selling 2,229 Xponance Inc.‚Aos holdings in Charles River Laboratories International were worth $2,784,000 as of its most recent SEC filing.Several other hedge funds also recently modified ...
9/24/2021 Campbell & CO Investment Adviser LLC Invests $425,000 in Charles River Laboratories International, Inc. (NYSE:CRL) Campbell & CO Investment Adviser LLC acquired a new position in shares of Charles River Laboratories International, Inc. (NYSE:CRL) in the 2nd quarter, HoldingsChannel reports. The firm acquired 1,150 shares of the medical research company‚Aos stock, valued at approximately $425,000. Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. BlackRock Inc. increased its holdings in shares of Charles River Laboratories ...
9/23/2021 Forsta AP Fonden Makes New $5.59 Million Investment in Charles River Laboratories International, Inc. (NYSE:CRL) - Ticker Report Ticker Report Forsta AP Fonden bought a new position in Charles River Laboratories International, Inc. (NYSE:CRL) in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 15,100 shares of the medical research company‚Aos stock, valued at approximately $5,586,000.Other hedge funds and other institutional investors also recently modified their holdings of the company. Centerpoint Advisors LLC boosted its position in ...
9/22/2021 Heritage Wealth Management LLC Acquires 364 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) Heritage Wealth Management LLC increased its holdings in Charles River Laboratories International, Inc. (NYSE:CRL) by 88.3% in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 776 shares of the medical research company‚Aos stock after buying an additional 364 shares during the period. Heritage Wealth Management LLC‚Aos holdings in Charles River Laboratories International were worth $287,000 as of ...
9/20/2021 Cigna Investments Inc. New Sells 300 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) Cigna Investments Inc. New trimmed its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 15.4% during the 2nd quarter, Holdings Channel.com reports. The fund owned 1,649 shares of the medical research company‚Aos stock after selling 300 shares during the quarter. Cigna Investments Inc. New‚Aos holdings in Charles River Laboratories International were worth $611,000 at the end of the most recent quarter. Other institutional investors ...
9/18/2021 2,815 Shares in Charles River Laboratories International, Inc. (NYSE:CRL) Purchased by Psagot Investment House Ltd. Dakota Financial News Psagot Investment House Ltd. purchased a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL) in the second quarter, according to the company in its most recent filing with the SEC. The firm purchased 2,815 shares of the medical research company‚Aos stock, valued at approximately $1,041,000. A number of other large investors have also recently added to or reduced their stakes in CRL. William Blair Investment ...
9/17/2021 Gulf International Bank UK Ltd Acquires Shares of 8,245 Charles River Laboratories International, Inc. (NYSE:CRL) American Banking News Gulf International Bank UK Ltd acquired a new stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL) during the 2nd quarter, according to its most recent 13F filing with the SEC. The firm acquired 8,245 shares of the medical research company‚Aos stock, valued at approximately $3,049,000.Several other institutional investors have also made changes to their positions in CRL. Fred Alger Management LLC purchased a new stake ...
9/16/2021 Charles River Laboratories International (NYSE:CRL) Lowered to ‚ÄúHold‚Äù at Zacks Investment Research The Markets Daily Zacks Investment Research cut shares of Charles River Laboratories International (NYSE:CRL) from a buy rating to a hold rating in a research note released on Wednesday, Zacks.com reports. They currently have $458.00 price target on the medical research company‚Aos stock. According to Zacks, ‚AuCharles River exited the second quarter of 2021 on a strong note, with better-than-expected revenues and earnings. Robust demand in the Biologics Testing ...
9/11/2021 PNC Financial Services Group Inc. Sells 1,568 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) - WKRB News PNC Financial Services Group Inc. lessened its stake in Charles River Laboratories International, Inc. (NYSE:CRL) by 27.4% in the second quarter, HoldingsChannel reports. The fund owned 4,160 shares of the medical research company‚Aos stock after selling 1,568 shares during the period. PNC Financial Services Group Inc.‚Aos holdings in Charles River Laboratories International were worth $1,539,000 at the end of the most recent quarter.Other hedge funds and ...
9/10/2021 HighTower Advisors LLC Buys 700 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) HighTower Advisors LLC boosted its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 3.8% during the second quarter, Holdings Channel reports. The institutional investor owned 18,973 shares of the medical research company‚Aos stock after acquiring an additional 700 shares during the quarter. HighTower Advisors LLC‚Aos holdings in Charles River Laboratories International were worth $7,019,000 as of its most recent filing with the Securities and ...
9/9/2021 Level Four Advisory Services LLC Increases Stock Holdings in Charles River Laboratories International, Inc. (NYSE:CRL) - Ticker Report Ticker Report Level Four Advisory Services LLC raised its stake in Charles River Laboratories International, Inc. (NYSE:CRL) by 6.3% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 2,176 shares of the medical research company‚Aos stock after purchasing an additional 128 shares during the quarter. Level Four Advisory Services LLC‚Aos holdings in Charles River Laboratories International were worth $805,000 ...
9/9/2021 Zacks: Analysts Expect Charles River Laboratories International, Inc. (NYSE:CRL) to Post $2.56 Earnings Per Share American Banking News Analysts predict that Charles River Laboratories International, Inc. (NYSE:CRL) will report earnings of $2.56 per share for the current fiscal quarter, according to Zacks Investment Research . Five analysts have made estimates for Charles River ... announced its quarterly earnings results on Tuesday, August 3rd. The medical research company reported $2.61 earnings per share (EPS) for the quarter, beating analysts‚Ao consensus estimates of $2.38 by $0.23. The company had revenue ...
9/9/2021 Zacks: Analysts Expect Charles River Laboratories International, Inc. (NYSE:CRL) to Post $2.56 Earnings Per Share Analysts predict that Charles River Laboratories International, Inc. (NYSE:CRL) will report earnings of $2.56 per share for the current fiscal quarter, according to Zacks Investment Research . Five analysts have made estimates for Charles River ... announced its quarterly earnings results on Tuesday, August 3rd. The medical research company reported $2.61 earnings per share (EPS) for the quarter, beating analysts‚Ao consensus estimates of $2.38 by $0.23. The company had revenue ...
9/9/2021 Analysts Anticipate Charles River Laboratories International, Inc. (NYSE:CRL) to Post $2.56 Earnings Per Share - WKRB News Brokerages expect that Charles River Laboratories International, Inc. (NYSE:CRL) will report $2.56 earnings per share for the current quarter, Zacks Investment Research reports. Five analysts have made estimates for Charles River Laboratories International‚Aos ... last released its earnings results on Tuesday, August 3rd. The medical research company reported $2.61 EPS for the quarter, topping the consensus estimate of $2.38 by $0.23. The firm had revenue of $914.61 million for ...
9/8/2021 Alpine Woods Capital Investors LLC Sells 80 Shares of Charles River Laboratories International, Inc. (NYSE:CRL) Alpine Woods Capital Investors LLC lessened its stake in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 4.5% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 1,695 shares of the medical research company‚Aos stock after selling 80 shares during the period. Alpine Woods Capital Investors LLC‚Aos holdings in Charles River Laboratories International were worth $627,000 as of its most recent filing with the SEC. A ...
9/8/2021 Charles River Laboratories International, Inc. (NYSE:CRL) Shares Sold by Brandywine Oak Private Wealth LLC - WKRB News Brandywine Oak Private Wealth LLC lowered its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL) by 14.0% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 794 shares of the medical research company‚Aos stock after selling 129 shares during the period. Brandywine Oak Private Wealth LLC‚Aos holdings in Charles River Laboratories ...